FDA approves Dova Pharma's blood disorder drug

(Reuters) - The U.S Food and Drug Administration has approved Dova Pharmaceuticals Inc's drug to treat thrombocytopenia, or low blood platelet count, in patients with chronic liver disease, the agency said on Monday.